Medical Illustration: Targeting HER2 in Gastric Cancer

April 15, 2016
Erin Moore

CURE, Gastrointestinal Special Issue, Volume 1, Issue 1

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

ILLUSTRATION BY ERIN MOORE

ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009

*HER2 is also associated with breast cancer.

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

Related Content:

PublicationsGastrointestinal CancersGastrointestinal Special Issue
Braftovi Regimen Is Promising in Metastatic Colorectal Cancer
Targeted Therapy Outperforms Standard Care in Metastatic Solid Cancers
Zynyz Plus Chemo Combo Improves Survival in Recurrent/Metastatic SCAC